Joubert-Pandita syndrome - Symptoms, Causes, Treatment & Prevention

```html

Overview

Joubert‑Pandita syndrome (JPS) is a very rare neurodevelopmental disorder that combines the classic features of Joubert syndrome with additional systemic findings that were first described by Dr. Pandita and colleagues in 2018. The hallmark brain anomaly is the “molar‑tooth sign” on magnetic resonance imaging (MRI), reflecting abnormal development of the cerebellar vermis and brainstem. In addition to the neurological picture, individuals with JPS often have congenital renal, hepatic, or skeletal anomalies, and an increased risk of endocrine abnormalities.

JPS is inherited in an autosomal recessive pattern, meaning that an affected child inherits a disease‑causing variant from each parent. Because the condition is so uncommon, the exact prevalence is not well defined, but estimates place it at fewer than 1 in 1,000,000 live births worldwide. It has been reported in multiple ethnic groups, with clusters in North‑African and South‑Asian families where consanguineous marriages are more common.

Symptoms

Symptoms can vary widely, even among siblings with the same genetic mutation. The following list represents the most frequently reported findings (reported in ≥30 % of cases) and includes brief descriptions.

• Neurological
  • Hypotonia* (low muscle tone) – often present at birth, leading to floppy‑infant appearance.
  • Ataxia* – uncoordinated movements, especially evident when the child learns to sit, stand, or walk.
  • Developmental delay* – delays in speech, language, and cognitive milestones; many children require early intervention services.
  • Abnormal eye movements* – nystagmus, oculomotor apraxia, or difficulty tracking objects.
  • Breathing dysregulation* – episodic hyperpnea (rapid breathing) or apnea, most pronounced in infancy.
  • Seizures* – reported in 20‑30 % of individuals, usually focal or generalized tonic‑clonic.
• Renal
  • Nephronophthisis or cystic kidney disease* – progressive loss of kidney function; may lead to end‑stage renal disease in adolescence or early adulthood.
• Hepatic
  • Congenital hepatic fibrosis* – can cause portal hypertension, splenomegaly, and variceal bleeding.
• Skeletal
  • Polydactyly* – extra fingers or toes; typically post‑axial (on the ulnar side).
  • Short ribs or vertebral anomalies* – may cause thoracic insufficiency.
• Endocrine
  • Growth hormone deficiency* – leading to short stature if untreated.
  • Hypothyroidism* – may be primary or central.
• Other
  • Facial dysmorphism* – broad nasal bridge, low-set ears, and a long philtrum.
  • Feeding difficulties* – due to poor suck‑swallow coordination; may require gastrostomy tube.
  • Hearing loss* – sensorineural in up to 15 % of cases.

Causes and Risk Factors

Joubert‑Pandita syndrome is caused by pathogenic variants in genes that encode proteins critical for ciliogenesis—the formation and function of primary cilia. The most commonly implicated genes are TMEM67, CEP290, AHI1, and CC2D2A. These genes belong to the broader group of “ciliopathies,” which also include classic Joubert syndrome, Meckel‑Gruber syndrome, and Bardet–Biedl syndrome.

Key risk factors:

• Consanguinity* – marriages between close relatives increase the chance both parents carry the same recessive mutation.
• Family history* – having an affected sibling or a known carrier parent.
• Ethnic background* – certain founder mutations have been identified in North‑African (e.g., Moroccan) and South‑Asian (e.g., Pakistani) populations.

Environmental factors have not been shown to cause JPS, but prenatal exposure to teratogens can aggravate the severity of congenital anomalies in a child already predisposed by genetics.

Diagnosis

Diagnosis relies on a combination of clinical assessment, neuro‑imaging, and molecular genetics.

1. Clinical evaluation

• Detailed prenatal and perinatal history.
• Physical exam focusing on neurological tone, eye movements, facial features, and presence of polydactyly.
• Developmental screening using tools such as the Bayley Scales of Infant Development.

2. Neuro‑imaging

• MRI of the brain – the definitive test. The “molar‑tooth sign” (deepened interpeduncular fossa, elongated superior cerebellar peduncles, and hypoplasia of the vermis) is pathognomonic.
• Serial MRIs may be needed to monitor cerebellar growth and detect secondary complications (e.g., hydrocephalus).

3. Genetic testing

• Targeted gene panels* for Joubert‑related ciliopathies – cost‑effective first step.
• Whole‑exome sequencing (WES) – recommended when panel results are negative but suspicion remains high.
• Parental carrier testing is essential for genetic counseling.

4. Ancillary studies

• Renal ultrasound and serum creatinine to assess kidney involvement.
• Liver function tests and abdominal MRI if hepatic fibrosis is suspected.
• Audiology evaluation and ophthalmologic exam (for coloboma, retinal dystrophy).
• Endocrine work‑up (TSH, free T4, IGF‑1) if growth or thyroid abnormalities are present.

Treatment Options

There is no cure for JPS; treatment is symptom‑directed and multidisciplinary.

Neurological management

• Physical and occupational therapy* – improves muscle tone, balance, and functional independence.
• Speech‑language therapy* – assists with language acquisition and feeding difficulties.
• Anticonvulsants* – e.g., levetiracetam or valproic acid for seizure control; choice guided by seizure type and side‑effect profile.
• Respiratory support* – nocturnal CPAP or BiPAP for children with persistent hypoventilation; in severe cases, gastrostomy with ventilatory weaning may be considered.

Renal care

• Regular monitoring of kidney function (eGFR, urine protein) every 6–12 months.
• Angiotensin‑converting enzyme (ACE) inhibitors or ARBs for proteinuria.
• Early referral for renal transplant evaluation when eGFR <30 mL/min/1.73 m².

Hepatic management

• Surveillance ultrasound for portal hypertension.
• Beta‑blockers or endoscopic band ligation for esophageal varices.
• Liver transplantation is rarely required but considered for decompensated cirrhosis.

Endocrine & growth

• Growth hormone therapy after confirming GH deficiency (dose 0.025 mg/kg/day subcutaneously).
• Thyroid hormone replacement for hypothyroidism (levothyroxine dosing per weight).

Surgical interventions

• Polydactyly removal – typically performed before age 2 to aid motor development.
• Orthopedic surgery for severe rib or vertebral anomalies that compromise breathing.

Supportive & psychosocial care

• Genetic counseling for families.
• Psychological support for caregivers; connection with patient advocacy groups (e.g., Joubert Syndrome Foundation).
• Educational planning – individualized education programs (IEPs) to accommodate learning needs.

Living with Joubert‑Pandita syndrome

Because JPS touches multiple organ systems, a coordinated care team is crucial. Below are practical tips for day‑to‑day management.

• Establish a medical home – a pediatric neurologist or geneticist who coordinates referrals.
• Routine surveillance schedule (example):
  • Neurology: every 6 months
  • Renal labs & ultrasound: annually (more often if declining function)
  • Liver panel & abdominal imaging: annually
  • Audiology & ophthalmology: every 1–2 years
  • Endocrine labs: yearly or as indicated
• Therapy consistency – attend PT/OT sessions 2–3 times per week; home exercises should be incorporated into playtime.
• Nutrition – high‑calorie, nutrient‑dense foods; consider a feeding specialist if oral intake is inadequate.
• Adaptive equipment – use of gait trainers, standing frames, and communication devices (AAC) improves independence.
• School integration – provide the school with a 504 plan or IEP outlining needed accommodations (e.g., extra time on tests, preferential seating).
• Family self‑care – caregiver burnout is common; seek respite services and connect with support groups.

Prevention

Because JPS is genetic, primary prevention focuses on informed reproductive choices.

• Carrier screening* – offered to couples with a known family history or from high‑risk ethnic groups.
• Pre‑implantation genetic testing (PGT‑M) – for couples undergoing in‑vitro fertilization, embryos can be screened for the pathogenic variants.
• Prenatal diagnosis* – chorionic villus sampling (CVS) or amniocentesis with targeted gene analysis can identify affected fetuses.
• Genetic counseling* – essential for understanding recurrence risk (25 % for each subsequent pregnancy in autosomal recessive inheritance).

Complications

If not appropriately monitored, JPS can lead to serious health problems.

• Progressive renal failure* – leading to dialysis or transplant.
• Portal hypertension and variceal bleeding* – life‑threatening hemorrhage.
• Severe respiratory insufficiency* – especially during infections; may require mechanical ventilation.
• Recurrent seizures* – risk of status epilepticus.
• Developmental regression* – if uncontrolled seizures or metabolic derangements occur.
• Psychosocial impact* – anxiety, depression, and reduced quality of life for both patient and family.

When to Seek Emergency Care

---

Sources: Mayo Clinic, National Institutes of Health (NIH) – National Center for Advancing Translational Sciences, Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), Cleveland Clinic, Journal of Medical Genetics (2020); American Journal of Medical Genetics (2019).

```